![](data:image/png;base64,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)
de Medicina y Cirugía
45
REPERT MED CIR. 2021;30(Supl. Núm.1):41-45
REFERENCIAS
1. Gudbjartsson DF, Helgason A, Jonsson H, Magnusson OT,
Melsted P, Norddahl GL. Spread of SARS-CoV-2 in the Icelandic
Population. N Engl J Med. 2020;382(24):2302-2315. doi: 10.1056/
NEJMoa2006100.
2. Huang C, Wang Y, Li X, Ren L, Zhao J, Hu Y, Zhang L, et al.
Clinical features of patients infected with 2019 novel coronavirus
in Wuhan, China. Lancet. 2020;395(10223):497-506. doi: 10.1016/
S0140-6736(20)30183-5
3. World Helath Organization. WHO Coronavirus (COVID-19)
Dashboard [Internet]. World Helath Organization; 2021
[consultado 6 de abril 2021]; Disponible en: https://covid19.who.
int/.
4. Krammer F. SARS-CoV-2 vaccines in development. Nature.
2020;586(7830):516-527. doi: 10.1038/s41586-020-2798-3
5. Walsh EE, Frenck Jr RW, Falsey AR, Kitchin N, Absalon J,
Gurtman A, et al. N Engl J Med. 2020;383(25):2439-2450. doi:
10.1056/NEJMoa202790
6. Wang J, Peng Y, Xu H, Cui Z, Williams RO. The COVID-19 Vaccine
Race: Challenges and Opportunities in Vaccine Formulation. AAPS
PharmSciTech. 2020;21(6):225. doi: 10.1208/s12249-020-01744-7
7. Rawat K, Kumari P, Saha, L. COVID-19 vaccine: A recent update in
pipeline vaccines, their design and development strategies. Eur J
Pharmacol. 2021;892:173751. doi: 10.1016/j.ejphar.2020.173751
8. Abbasi K. Behavioural fatigue: a awed idea central to a awed
pandemic response. BMJ. 2020;370:m3093. doi: 10.1136/bmj.
m3093
9. Rypdal K, Bianchi FM, Rypdal, M. Intervention Fatigue is the
Primary Cause of Strong Secondary Waves in the COVID-19
Pandemic. Int J Environ Res Public Health. 2020;17(24):9592. doi:
10.3390/ijerph17249592
10. Priesemann V, Brinkmann MM, Ciesek S, Cuschieri S, Czypionka T,
et al. Calling for pan-European commitment for rapid and sustained
reduction in SARS-CoV-2 infections. Lancet. 2021;397(10269):92-
93. doi: 10.1016/S0140-6736(20)32625-8
11. Priesemann V, Brinkmann MM, Ciesek S, Cuschieri S, Czypionka T,
et al. Calling for pan-European commitment for rapid and sustained
reduction in SARS-CoV-2 infections. Lancet. 2021;397(10269):92-
93. doi: 10.1016/S0140-6736(20)32625-8
12. Davies NG, Abbott S, Barnard RC, Jarvis CI, Kucharski AJ, et al.
Estimated transmissibility and impact of SARS-CoV-2 lineage
B.1.1.7 in England. Science. 2021;372(6538):eabg3055. doi:
10.1126/science.abg3055
13. Abbott S, Funk S, CMMID COVID-19 Working Group. Local area
reproduction numbers and S-gene target failure [Internet]. Centre
for Mathematical Modelling of Infectious Diseases 2021. [Citado
10 de junio de 2021]; Disponible en: https://cmmid.github.io/
topics/covid19/local-r-sgtf.html
14. Horby P, Huntley C, Davies N, Edmunds J, Ferguson N, Medley
G, Semple C. NERVTAG paper on COVID-19 variant of concern
B.1.1.7. Department of Health and Social Care. [Citado 10 de
junio de 2021]; Disponible en: https://www.gov.uk/government/
publications/nervtag-paper-on-covid-19-variant-of-concern-b117
15. Bubar KM, Reinholt K, Kissler SM, Lipsitch M, Cobey S, Grad YH.
Model-informed COVID-19 vaccine prioritization strategies by age
and serostatus. Science. 2021;371(6532):916–921. doi: 10.1126/
science.abe6959
16. Ramos AM, Vela-Pérez M, Ferrández MR, Kubik AB, Ivorra B.
Modeling the impact of SARS-CoV-2 variants and vaccines on
the spread of COVID-19. Preprint in ResearchGate. [Citado 10
de junio de 2021]; Disponible en: https://doi.org/10.13140/
RG.2.2.32580.24967/2
17. Suárez-Ibujes M. Coeciente de correlación de Karl Pearson
[Internet]. 2021. [citado 14 mayo 2021]; Disponible en: https://
www.monografias.com/trabajos85/coeficiente-correlacion-karl-
pearson/coeciente-correlacion-karl-pearson.shtml
18. Díaz Pinzón, JE. Medidas de frecuencia por COVID-19 en Bogotá
DC. Repert Med Cir. 2020;29(Núm. Supl.1):94-98. https://doi.
org/10.31260/RepertMedCir.01217372.1110
19. Díaz Pinzón JE. Estimación de la prevalencia del COVID-19 en
Colombia. Repert Med Cir. 2020;29(Núm. Supl.1):99-102. https://
doi.org/10.31260/RepertMedCir.01217372.1115
20. Díaz Pinzón JE. Estimación de las tasas de mortalidad y letalidad por
COVID-19 en Colombia. Repert Med Cir. 2020;29(Núm. Supl.1):89-
93. https://doi.org/10.31260/RepertMedCir.01217372.1103
por COVID-19. Este estudio aporta los primeros datos del
país sobre el impacto de la vacuna contra el SARS-COV-2
en la población, que demuestran como la campaña aún no
ha sido efectiva. Aunque el hallazgo es preliminar, tiene
importante implicación en la salud pública para el combate
contra la pandemia de COVID-19. Se requieren más estudios
predestinados a evaluar la ecacia de la vacunación en la
reducción de la transmisión del SARS-CoV-2, tanto a nivel
individual como a nivel poblacional, con un mayor rastreo
longitudinal y en poblaciones adicionales.